| European Case Law Identifier: | ECLI:EP:BA:2018:T105012.20180122 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 22 January 2018 | ||||||||
| Case number: | T 1050/12 | ||||||||
| Application number: | 05000057.9 | ||||||||
| IPC class: | A61K 35/34 C12N 5/08 A61P 13/02 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence | ||||||||
| Applicant name: | UNIVERSITY OF PITTSBURGH | ||||||||
| Opponent name: | Innovacell Biotechnologie AG | ||||||||
| Board: | 3.3.01 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Referral to the Enlarged Board of Appeal - (no) Remittal to the department of first instance - (no) Novelty - (no) - meeting abstracts available to library users before priority date - enabling disclosure for medical indication Amendments - intermediate generalisation Late-filed auxiliary requests |
||||||||
| Catchwords: |
Meeting abstracts published in a supplement to a regular volume of a scientific journal found to be publicly available before the priority date of the patent on the basis of library date-stamps and accompanying declarations of the librarians (see Reasons 3.1 to 3.5). |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t121050eu1.html
Date retrieved: 17 May 2021
